TERMIUM Plus®

The Government of Canada’s terminology and linguistic data bank.

TRANSITION CELL CARCINOMA [1 record]

Record 1 1997-11-06

English

Subject field(s)
  • Cytology
CONT

The Food and Drug Administration has approved an enzyme immunoassay for the in vitro quantitative determination of nuclear matrix protein NMP22 in stabilized voided urine, the Matritech NMP22R Test Kit (Matritech Inc.). The test kit is indicated as an aid in the management of patients with transition cell carcinoma of the urinary tract, after surgical treatment to identify those patients with occult or rapidly recurring cancer.

French

Domaine(s)
  • Cytologie
CONT

Parmi les affections malignes du système urinaire, le cancer de la vessie ou carcinome des cellules de transition (TCC) est le plus répandu. Pour les seuls États-Unis, par exemple, il touche 51 000 personnes.

Spanish

Save record 1

Copyright notice for the TERMIUM Plus® data bank

© Public Services and Procurement Canada, 2024
TERMIUM Plus®, the Government of Canada's terminology and linguistic data bank
A product of the Translation Bureau

Features

Language Portal of Canada

Access a collection of Canadian resources on all aspects of English and French, including quizzes.

Writing tools

The Language Portal’s writing tools have a new look! Easy to consult, they give you access to a wealth of information that will help you write better in English and French.

Glossaries and vocabularies

Access Translation Bureau glossaries and vocabularies.

Date Modified: